Aura Biosciences, Inc. (AURA) Total Return Calculator with Dividends Reinvested

Aura Biosciences, Inc.

Popular:

The total return for Aura Biosciences, Inc. (AURA) stock is -3.90% over the past 12 months. So far it's up 20.94% this year. The 5-year total return is -56.69%, meaning $10,000 invested in AURA stock 5 years ago would be worth $4,331 today. Total return includes price appreciation plus reinvesting any dividends paid out.

If you invested $10,000 in AURA 1 year ago, it would be worth $9,984 today — you'd have lost $16.

With Dividends Reinvested$9,984-0.16%

Price Only (No DRIP)$9,984-0.16%

Period2025-06-13 → 2026-06-12

Price

Total Return (DRIP)

S&P 500

If You Invested $10,000 in AURA

1Y$9,610-$390 (-3.9%)-3.9% CAGR

3Y$5,124-$4,876 (-48.8%)-20.0% CAGR

5Y$4,331-$5,669 (-56.7%)-15.4% CAGR

10Y$4,331-$5,669 (-56.7%)-8.0% CAGR

15Y$4,331-$5,669 (-56.7%)-5.4% CAGR

20Y$4,331-$5,669 (-56.7%)-4.1% CAGR

30Y$4,331-$5,669 (-56.7%)-2.8% CAGR

Aura Biosciences, Inc. did not pay dividends during this period. Total return = price return.

Loading AURA total return...

As of 2026-06-13

Returns at a Glance

Period	Total Return	CAGR	Price Only	Div. Contrib.	$10K →
YTD	+20.94%	—	+20.94%	—	$12,094
1Y	-3.90%	-3.90%	-3.90%	—	$9,610
3Y	-48.76%	-19.98%	-48.76%	—	$5,124
5Y	-56.69%	-15.41%	-56.69%	—	$4,331
10Y	-56.69%	-8.03%	-56.69%	—	$4,331
15Y	-56.69%	-5.43%	-56.69%	—	$4,331
20Y	-56.69%	-4.10%	-56.69%	—	$4,331
30Y	-56.69%	-2.75%	-56.69%	—	$4,331

Risk & Highlights

Best Year+14.73%2021

Worst Year-44.12%2022

Max Drawdown-31.26%2025-08-13 → 2026-01-20 · Recovered 2026-04-17

Annual Returns

Year	Total Return	Price Return	Div.	S&P 500	vs S&P
2026YTD	+11.13%	+11.13%	—	+0.41%	+10.7pp
2025	-34.02%	-34.02%	—	+16.64%	-50.7pp
2024	-8.97%	-8.97%	—	+24.00%	-33.0pp
2023	-16.96%	-16.96%	—	+24.81%	-41.8pp
2022	-44.12%	-44.12%	—	-19.95%	-24.2pp

AURA underperformed the S&P 500 by 26.76pp over the past year (-3.90% vs +22.86%).

Loading summary...

AURA Peers' Total Return

Accurate peer set · 10 comparable names

Name	Mkt Cap	30D Rtn	YTD Total Rtn	1Y Total Rtn	Div Contrib	3Y Total Rtn	5Y Total Rtn	10Y Total Rtn
AURAAura Biosciences, Inc.	$412M	-19.2%	+20.9%	-3.9%	—	-48.8%	-56.7%	-56.7%
OCULOcular Therapeutix, Inc.	$2.0B	-2.4%	-24.4%	-0.1%	—	+37.5%	-36.9%	+39.7%
RCKTRocket Pharmaceuticals, Inc.	$300M	-24.5%	-20.5%	-10.4%	—	-88.0%	-94.2%	-91.1%
ADVMAdverum Biotechnologies, Inc.	$96M	—	—	+68.3%	—	-71.5%	-88.2%	-88.2%
REPLReplimune Group, Inc.	$733M	+117.1%	-0.2%	-10.2%	—	-62.1%	-74.4%	-41.4%
IMVTImmunovant, Inc.	$6.9B	+17.3%	+29.8%	+110.9%	—	+55.0%	+213.0%	+237.9%
NUVLNuvalent, Inc.	$9.1B	+20.2%	+22.2%	+58.2%	—	+183.3%	+557.3%	+557.3%
SGHTSight Sciences, Inc.	$279M	+4.1%	-31.4%	+21.9%	—	-36.4%	-84.7%	-84.7%
LNTHLantheus Holdings, Inc.	$6.8B	+8.6%	+55.4%	+30.4%	—	+24.5%	+330.3%	+3673.3%
AGENAgenus Inc.	$137M	-4.1%	+2.2%	-31.5%	—	-91.8%	-96.8%	-95.9%
IMCRImmunocore Holdings plc	$1.5B	-1.2%	-14.3%	-18.7%	—	-50.1%	-27.1%	-33.0%

Compare:AURA vs OCUL AURA vs RCKT AURA vs ADVM AURA vs OCUL vs RCKT

About AURA Dividend Returns

Aura Biosciences, Inc. (AURA) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.

How We Calculate Total Return

Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.

Frequently Asked Questions

Q1What is the total return of AURA over the past year?

Aura Biosciences, Inc. (AURA) delivered a return of -3.90% over the past year. Since AURA does not currently pay dividends, the total return equals the price-only return.

Q2How much would $10,000 invested in AURA be worth today?

A $10,000 investment in Aura Biosciences, Inc. one year ago would be worth $9,610 today, representing a loss of $390.

Q3Does AURA pay dividends?

Aura Biosciences, Inc. (AURA) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For AURA, the total return equals the price-only return.

Q4Did AURA beat the S&P 500?

No, Aura Biosciences, Inc. (AURA) underperformed the S&P 500 by 26.76 percentage points over the past year. AURA delivered a total return of -3.90%, compared to the S&P 500's 22.86%. This means a passive S&P 500 index fund outperformed AURA by 26.76pp during this period.

Q5What is AURA's worst drawdown?

Aura Biosciences, Inc. (AURA) experienced a maximum drawdown of -31.26% over the past year, declining from its peak on 2025-08-13 to its trough on 2026-01-20. The stock recovered to its prior peak by 2026-04-17. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Q6What is AURA's long-term total return over 10, 20, or 30 years?

Here are Aura Biosciences, Inc. (AURA)'s long-term returns with dividends reinvested. Over 10 years, the total return is -56.7% (-8.0% CAGR) — $10,000 would have grown to $4,331. Over 20 years: -56.7% total return (-4.1% CAGR) — $10,000 → $4,331. Over 30 years: -56.7% total return (-2.8% CAGR) — $10,000 → $4,331. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Q7What was AURA's best and worst year?

Aura Biosciences, Inc.'s best calendar year was 2021 with a total return of 14.7%. Its worst year was 2022 with a total return of -44.1%. This range shows the volatility investors should expect — the difference between the best and worst year is 58.8 percentage points.

How much would $100/month in AURA be worth today?

Dollar cost averaging calculator · DCA vs lump sum · see how regular investing compounds

Run the Numbers →